Author:
Xu Wen-fu,Wang Zhu-jun,Li Kun,Shen Ya-qing,Lu Ke,Lv Xue-yan,Wen Yu-xi,Jin Run-ming
Publisher
Springer Science and Business Media LLC
Reference52 articles.
1. Deininger MW, Vieira S, Mendiola R, et al. BCR-ABL tyrosine kinase activity regulates the expression of multiple genes implicated in the pathogenesis of chronic myeloid leukemia. Cancer Res, 2000,60(7):2049–2055
2. An X, Tiwari AK, Sun Y, et al. BCR-ABL tyrosine kinase inhibitors in the treatment of Philadelphia chromosome positive chronic myeloid leukemia: a review. Leuk Res, 2010,34(10):1255–1268
3. von Bubnoff N, Peschel C, Duyster J. Resistance of Philadelphia-chromosome positive leukemia towards the kinase inhibitor imatinib (STI571, Glivec): a targeted oncoprotein strikes back. Leukemia, 2003,17(5):829-838
4. La Rosee P, Deininger MW. Resistance to imatinib: mutations and beyond. Semin Hematol, 2010,47(4):335-343
5. Lee HJ, Thompson JE, Wang ES, et al. Philadelphia chromosome-positive acute lymphoblastic leukemia: current treatment and future perspectives. Cancer, 2011,117(8):1583–1594
Cited by
2 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献